Skip to Content

WPI 3660 (Desvenlafaxine Succinate Extended-Release 100 mg (base))

Pill with imprint WPI 3660 is Orange, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 100 mg (base). It is supplied by Actavis Pharma, Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3660

Desvenlafaxine succinate extended-release 100 mg (base) WPI 3660

Desvenlafaxine Succinate Extended-Release

Imprint
WPI 3660
Strength
100 mg (base)
Color
Orange
Size
12.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-3660
Inactive Ingredients
hypromelloses, microcrystalline cellulose, magnesium silicate, magnesium stearate, silicon dioxide, titanium dioxide, ferric oxide yellow, ferric oxide red, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.